J&J directors off the hook for quality meltdown; Man killed in India plant explosion;

> A judge has dismissed a lawsuit against Johnson & Johnson ($JNJ) directors brought by shareholders who accused them of ignoring indications of product manufacturing problems that eventually led to a host of product recalls. Article

> A man was killed and two more were injured when a vacuum cylinder exploded in a pharma manufacturing unit of Vidya Herbals in India. Story

> Failure to conduct any specific identity test of drug ingredients and to establish the reliability of supplier's analyses through periodic validation are among the violations described in a warning letter to Dental Technologies in Lincolnwood, IL. Warning Letter CHI-18-11

> Stirling pharma plant for sale in Nova Scotia: 46,000 square feet, GMP compliant, and with the unique capability to assist clients in bringing products from development through scale-up to commercial production. Story

> Toronto-based Patheon ($TSK:PTI) says the president of its North American operations, Peter Bigelow, will leave the company Nov. 1, to pursue other opportunities, but will remain a consultant as the company continues its drive to return to profitability. Article

> CMO Vetters has announced that its first U.S. site, a 24,000-square-foot plant in suburban Chicago, is fully operational. Release

> Sanofi's ($SNY) Pasteur unit, which acquired Shantha Biotechnics in 2009, will soon unveil a new vaccine manufacturing facility in Hyderabad. Story

> Yusen Logistics will provide international supply chain services for U.K. drugmaker ProStrakan. Report